Product Information
REXULTI 4 MG TABLET is a brand product labeled by Otsuka America Pharmaceutical Inc., priced at $49.5005 per EA under NDC 59148004013. Its NADAC has been published 540 times since Apr 20, 2016.
FDA first approved this application on Jul 10, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Otsuka America Pharmaceutical Inc.NDC
59148004013
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BREXPIPRAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA205422FDA Approved
7/10/2015
TE Code
AB
On Market Since
7/10/2015
Pharmacological Classes
Price Statistics
The NADAC for REXULTI 4 MG TABLET has been published 540 times since Apr 20, 2016, and over the history we have for it it has risen 74.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $49.5005 per EA |
|---|---|
| All-time high | $49.6310 (May 13, 2026) |
| All-time low | $28.3809 (Apr 20, 2016) |
| 52-week high | $49.6310 |
| 52-week low | $48.2848 |
| Median price | $39.7070 |
| Average price | $40.1375 |
| Largest weekly change | +9.9% (Apr 11, 2018) |
| Weeks tracked | 540 |
| Tracking since | Apr 20, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the brexpiprazole market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of REXULTI 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for REXULTI 4 MG TABLET, manufactured by Otsuka America Pharmaceutical Inc., is $49.5005 per EA (NDC 59148004013), effective Aug 19, 2026.
How has the price of REXULTI 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for REXULTI 4 MG TABLET has risen 74.4%. It has been tracked across 540 weekly CMS publications since Apr 20, 2016.
What are the highest and lowest recorded NADAC prices for REXULTI 4 MG TABLET?
Since Apr 20, 2016, the NADAC for REXULTI 4 MG TABLET has ranged from a low of $28.3809 (Apr 20, 2016) to a high of $49.6310 (May 13, 2026), with a median of $39.7070 per EA.
Are there cheaper alternatives to REXULTI 4 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of REXULTI 4 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures REXULTI 4 MG TABLET?
REXULTI 4 MG TABLET (NDC 59148004013) is labeled by Otsuka America Pharmaceutical Inc., and CMS classifies it as a brand product.